Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04322370 · ClinicalTrials.gov registry record · NA
Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries
A NA study of Flexor Tendon, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT04322370 is a NA study of Flexor Tendon that is actively recruiting participants, run by University of Florida. The registered enrollment target is 42 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04322370, a NA study of Flexor Tendon, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
To analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is current SOC at UF.
Conditions Studied
Interventions
- PROCEDURE Standard of Care Surgical Procedure
- DEVICE VersaWrap Treatment
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-08-21 |
| Est. Completion | 2027-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04322370
The ClinicalTrials.gov registry entry for NCT04322370 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Flexor Tendon appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care Surgical Procedure is the first listed.
NCT04322370 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04322370 about?
NCT04322370 is a clinical study titled "Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries". To analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is current SOC at UF.
What is the current status of trial NCT04322370?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2020-08-21. Estimated completion is 2027-05-17.
What conditions does trial NCT04322370 study?
This clinical trial studies the following conditions: Flexor Tendon.
What interventions are being tested in trial NCT04322370?
The interventions under investigation include: Standard of Care Surgical Procedure (PROCEDURE), VersaWrap Treatment (DEVICE).
Who is sponsoring clinical trial NCT04322370?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04322370 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.